M K Proteins seeks approval for ₹135 crore related party deals at AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • M K Proteins schedules 14th AGM for September 30, 2026, via video conference
  • Seeks approval for ₹135 crore in related-party transactions for FY27
  • Proposes appointment of Ms. Aritika Garg as Independent Director
  • Re-appointment of Sh. Raj Kumar, retiring by rotation, also on agenda
powered bylight_fuzz_icon
49894864

*this image is generated using AI for illustrative purposes only.

M K Proteins has scheduled its 14th Annual General Meeting for September 30, 2026. The meeting will convene at 11:00 am via video conference or other audio-visual means to transact ordinary and special business items.

The board approved the notice and directors report for the fiscal year ended March 31, 2026. Key agenda items include the ratification of cost auditor remuneration, the appointment of an independent director, and omnibus approvals for material related party transactions. The company also dispatched letters to members providing web links to access the Annual Report for FY25-26.

Corporate Action Details

The board meeting commenced at 3:00 pm and concluded at 3:30 pm on September 2, 2026. Directors approved the following items:

  • Notice of the 14th Annual General Meeting
  • Directors Report along with annexures
  • Appointment of Ms. Aritika Garg as Independent Director
  • Ratification of remuneration for Cost Auditors for FY27
  • Approval for material transactions with related parties Kamla Oleo Private Limited and Kamla Oils and Fats Private Limited

The notice of the AGM and the annual report will be dispatched to shareholders and stock exchanges separately in due course. Shareholders without registered email IDs have been sent letters with web links and QR codes to access the documents.

Book Closure Period

Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the register of members and share transfer books will remain closed.

Event Date
Cut-off Date for E-voting September 23, 2026
Commencement of E-voting September 27, 2026
Conclusion of E-voting September 29, 2026
Book Closure Start September 24, 2026
Book Closure End September 30, 2026
AGM Date September 30, 2026

The closure period includes both start and end dates. Shareholders on record during this window will be eligible to attend the meeting and vote on resolutions. The Board has not recommended any dividend for FY26.

Related Party Transactions

Shareholders are requested to approve omnibus approvals for material related party transactions with two entities for FY27. These approvals are valid until the next AGM in 2027.

Related Party Entity Proposed Transaction Value (₹ crore) Nature of Transaction
Kamla Oleo Private Limited 80 Sale/purchase of goods including Palm Fatty Acid, Non-Edible Oil, Rice Bran Oil and Chemicals
Kamla Oils and Fats Private Limited 55 Sale/purchase of goods including Rice Bran Oil and other Vegetable Oils

The proposed transaction value with Kamla Oleo represents 20.89% of the listed entity's annual consolidated turnover for the preceding financial year. The transaction with Kamla Oils and Fats represents 14.36%. Directors Mr. Parmod Kumar, Mr. Vinod Kumar, Mr. Raj Kumar and Mr. Parvind Kumar have an interest in these transactions by virtue of their directorships or familial relationships with the related parties.

Board Appointments

Ms. Aritika Garg (DIN: 11895058) is recommended for appointment as an Independent Director for a first term of five consecutive years, effective from August 22, 2026. She is a qualified Chartered Accountant with over 15 years of experience in accounting, finance, taxation, and audit.

Additionally, shareholders are asked to re-appoint Sh. Raj Kumar (DIN: 00126983), who retires by rotation at this meeting. He is eligible and has offered himself for re-appointment.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE964W01021/42c16138-0e3b-488c-bd9e-2aac6c73f62a.pdf

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.55%-0.25%-2.66%-9.46%-40.88%+16.52%

How might the significant volume of related party transactions with Kamla Oleo and Kamla Oils impact M K Proteins' operational independence and profit margins in FY27?

What specific strategic expertise or governance improvements does Ms. Aritika Garg bring to the board that could influence the company's future financial oversight?

Given the board's decision not to recommend a dividend for FY26, what are the company's stated plans for capital allocation or reinvestment in the coming fiscal year?

M K Proteins appoints Aritika Garg as independent director

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • M K Proteins appointed Ms. Aritika Garg as an additional independent director on August 22, 2026
  • The Chartered Accountant has over 15 years of experience in finance, audit, and taxation
  • Her five-year tenure is subject to approval by shareholders at the upcoming AGM
  • She holds no other listed directorships and has no relationship with existing board members
powered bylight_fuzz_icon
48939504

*this image is generated using AI for illustrative purposes only.

M K Proteins has appointed Ms. Aritika Garg as an additional independent director on its Board of Directors. The appointment was approved during the company’s board meeting held on August 22, 2026.

Ms. Garg, a qualified Chartered Accountant with over 15 years of experience, will serve in the capacity of a Non-Executive Independent Director. Her appointment is subject to the approval of members at the company’s ensuing Annual General Meeting (AGM).

Director Profile

Ms. Garg possesses professional expertise in accounting, finance, taxation, audit, and related corporate matters. The board determined that her knowledge and skills are relevant for discharging the responsibilities of an Independent Director.

Particulars Details
Name & DIN Ms. Aritika Garg (DIN: 11895058)
Appointment Date August 22, 2026
Tenure Five years, subject to shareholder approval
Other Listed Directorships Nil
Relationship with Existing Directors None

The disclosure confirms that Ms. Garg is not related to any existing directors on the board. She is not debarred from holding the office of director by virtue of any SEBI order or other regulatory authority.

Regulatory Compliance

The appointment aligns with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 3:00 pm and concluded at 3:30 pm on August 22, 2026.

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.55%-0.25%-2.66%-9.46%-40.88%+16.52%

How might Ms. Garg's expertise in taxation and audit influence MK Proteins' financial reporting strategies or regulatory compliance posture in the coming fiscal year?

What specific governance reforms or strategic initiatives is the board likely to prioritize with the addition of an independent director possessing this specific professional background?

Given that the appointment is subject to AGM approval, are there any indications of shareholder sentiment or potential dissent regarding board composition changes?

More News on MK Proteins

1 Year Returns:-40.88%